Virtus ETF Advisers’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,043
| Closed | -$75.6K | – | 441 |
|
|
2023
Q1 | $75.6K | Sell |
1,043
-401
| -28% | -$29.1K | 0.04% | 393 |
|
|
2022
Q4 | $118K | Buy |
1,444
+634
| +78% | +$52K | 0.06% | 420 |
|
|
2022
Q3 | $77K | Buy |
810
+6
| +0.7% | +$570 | 0.03% | 429 |
|
|
2022
Q2 | $157K | Buy |
804
+409
| +104% | +$79.9K | 0.06% | 315 |
|
|
2022
Q1 | $92K | Sell |
395
-23
| -6% | -$5.36K | 0.04% | 315 |
|
|
2021
Q4 | $165K | Sell |
418
-162
| -28% | -$63.9K | 0.06% | 307 |
|
|
2021
Q3 | $259K | Sell |
580
-30
| -5% | -$13.4K | 0.11% | 215 |
|
|
2021
Q2 | $237K | Buy |
610
+99
| +19% | +$38.5K | 0.1% | 226 |
|
|
2021
Q1 | $184K | Buy |
511
+8
| +2% | +$2.88K | 0.08% | 334 |
|
|
2020
Q4 | $247K | Sell |
503
-811
| -62% | -$398K | 0.1% | 316 |
|
|
2020
Q3 | $426K | Sell |
1,314
-180
| -12% | -$58.4K | 0.22% | 156 |
|
|
2020
Q2 | $544K | Buy |
1,494
+563
| +60% | +$205K | 0.26% | 137 |
|
|
2020
Q1 | $198K | Sell |
931
-136
| -13% | -$28.9K | 0.08% | 276 |
|
|
2019
Q4 | $439K | Buy |
1,067
+605
| +131% | +$249K | 0.07% | 227 |
|
|
2019
Q3 | $163K | Sell |
462
-26
| -5% | -$9.17K | 0.03% | 273 |
|
|
2019
Q2 | $245K | Buy |
+488
| New | +$245K | 0.05% | 279 |
|
|
2016
Q4 | – | Sell |
-506
| Closed | -$271K | – | 181 |
|
|
2016
Q3 | $271K | Hold |
506
| – | – | 0.13% | 110 |
|
|
2016
Q2 | $285K | Buy |
506
+49
| +11% | +$27.6K | 0.21% | 67 |
|
|
2016
Q1 | $218K | Sell |
457
-28
| -6% | -$13.4K | 0.3% | 72 |
|
|
2015
Q4 | $321K | Buy |
+485
| New | +$321K | 0.88% | 28 |
|